View Future GrowthDawei Technology (Guangdong) Group 過去の業績過去 基準チェック /06Dawei Technology (Guangdong) Groupは57.6%の年平均成長率で業績を伸ばしているが、IT業界はdecliningで4.9%毎年増加している。売上は減少しており、年平均22.9%の割合である。主要情報57.57%収益成長率58.00%EPS成長率IT 業界の成長7.47%収益成長率-22.91%株主資本利益率-16.28%ネット・マージン-22.30%前回の決算情報31 Mar 2026最近の業績更新お知らせ • Mar 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Dec 26Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026お知らせ • Sep 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • Jun 30Dawei Technology (Guangdong) Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025お知らせ • Mar 28Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Dec 27Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 19, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 19, 2025すべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lijun Deng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 22+ 1 more updateDawei Technology (Guangdong) Group Co., Ltd. announced that it expects to receive CNY 300 million in fundingDawei Technology (Guangdong) Group Co., Ltd announced a private placement to issue A shares at an issue price of not less than 80% of the average price in the 20 trading days before the pricing reference date for gross proceeds of not more than CNY 300,000,000 on April 20, 2026. The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved in the 7th Meeting of the 10th Directorate and is subject to Company’s Annual Shareholders Meeting of 2025 for approval. The transaction will include participation from not more than 35 investors.お知らせ • Mar 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Dec 26Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026お知らせ • Sep 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • Jun 30Dawei Technology (Guangdong) Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025お知らせ • Mar 28Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Mar 19Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025, at 15:00 China Standard Time. Location: 13F, Tower B, 33 Building, Xiaoyun Road, Maizidian Subdistrict, Chaoyang District, Beijing Chinaお知らせ • Dec 27Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 19, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 19, 2025Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.005 (vs CN¥0.061 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.005 (up from CN¥0.061 loss in 3Q 2023). Revenue: CN¥101.2m (up 8.1% from 3Q 2023). Net income: CN¥9.55m (up CN¥52.5m from 3Q 2023). Profit margin: 9.4% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥3.70, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.お知らせ • Sep 30Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 21Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥2.55, the stock trades at a trailing P/E ratio of 30.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.New Risk • Sep 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Large one-off items impacting financial results.Reported Earnings • Aug 23Second quarter 2024 earnings released: CN¥0.039 loss per share (vs CN¥0.053 loss in 2Q 2023)Second quarter 2024 results: CN¥0.039 loss per share. Revenue: CN¥106.6m (up 13% from 2Q 2023). Net loss: CN¥41.6m (loss widened 12% from 2Q 2023).New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).お知らせ • Jun 28Guangdong Rongtai Industry Co.,Ltd to Report First Half, 2024 Results on Aug 23, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report first half, 2024 results on Aug 23, 2024Valuation Update With 7 Day Price Move • Jun 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥3.14, the stock trades at a trailing P/E ratio of 36.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥3.99, the stock trades at a trailing P/E ratio of 46x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 107% over the past three years.Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Supervisor Weibin Xu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥4.00, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years.お知らせ • Mar 29Guangdong Rongtai Industry Co.,Ltd to Report Q1, 2024 Results on Apr 26, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Mar 19Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024, at 15:00 China Standard Time. Location: 13F, Tower B, No. 33, Xiaoyun Road, Chaoyang District, Beijing ChinaReported Earnings • Mar 19Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥1.06 loss in FY 2022)Full year 2023 results: EPS: CN¥0.06 (up from CN¥1.06 loss in FY 2022). Revenue: CN¥366.8m (down 13% from FY 2022). Net income: CN¥82.6m (up CN¥828.0m from FY 2022). Profit margin: 23% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.New Risk • Jan 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥200m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-CN¥791m). Earnings have declined by 29% per year over the past 5 years. Shareholders have been substantially diluted in the past year (110% increase in shares outstanding).お知らせ • Dec 30Guangdong Rongtai Industry Co.,Ltd to Report Fiscal Year 2023 Results on Mar 22, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report fiscal year 2023 results on Mar 22, 2024お知らせ • Sep 30Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2023 Results on Oct 28, 2023Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Xiaoxuan Liu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.New Risk • Aug 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥279m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥279m free cash flow). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Negative equity (-CN¥748m). Earnings have declined by 35% per year over the past 5 years.New Risk • Aug 10New major risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CN¥711m). Earnings have declined by 40% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).Reported Earnings • Apr 26Full year 2022 earnings released: CN¥1.06 loss per share (vs CN¥1.01 loss in FY 2021)Full year 2022 results: CN¥1.06 loss per share (further deteriorated from CN¥1.01 loss in FY 2021). Revenue: CN¥421.1m (down 46% from FY 2021). Net loss: CN¥745.4m (loss widened 5.1% from FY 2021). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 27Third quarter 2022 earnings released: CN¥0.003 loss per share (vs CN¥0.053 loss in 3Q 2021)Third quarter 2022 results: CN¥0.003 loss per share (improved from CN¥0.053 loss in 3Q 2021). Net loss: CN¥2.05m (loss narrowed 95% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.Reported Earnings • Aug 27Second quarter 2022 earnings released: CN¥0.046 loss per share (vs CN¥0.025 profit in 2Q 2021)Second quarter 2022 results: CN¥0.046 loss per share (down from CN¥0.025 profit in 2Q 2021). Revenue: CN¥119.3m (down 58% from 2Q 2021). Net loss: CN¥31.2m (down 278% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.019 loss per share (vs CN¥0.018 loss in 1Q 2021)First quarter 2022 results: CN¥0.019 loss per share (down from CN¥0.018 loss in 1Q 2021). Revenue: CN¥198.6m (down 28% from 1Q 2021). Net loss: CN¥13.6m (loss widened 8.3% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.Reported Earnings • Oct 31Third quarter 2021 earnings released: CN¥0.053 loss per share (vs CN¥0.002 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥236.7m (down 9.6% from 3Q 2020). Net loss: CN¥37.3m (down CN¥38.6m from profit in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 28Second quarter 2021 earnings released: EPS CN¥0.025 (vs CN¥0.012 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥284.9m (up 14% from 2Q 2020). Net income: CN¥17.5m (up 106% from 2Q 2020). Profit margin: 6.1% (up from 3.4% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.Reported Earnings • May 03Full year 2020 earnings released: CN¥1.73 loss per share (vs CN¥0.76 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CN¥1.07b (down 27% from FY 2019). Net loss: CN¥1.22b (loss widened 126% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Jan 25New 90-day low: CN¥2.82The company is down 27% from its price of CN¥3.84 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period.Is New 90 Day High Low • Jan 06New 90-day low: CN¥3.18The company is down 22% from its price of CN¥4.08 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.Is New 90 Day High Low • Dec 14New 90-day low: CN¥3.49The company is down 19% from its price of CN¥4.31 on 16 September 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥831.7m, with earnings decreasing by CN¥1.17b from the prior year. Total revenue was CN¥1.14b over the last 12 months, down 27% from the prior year.Is New 90 Day High Low • Oct 29New 90-day low: CN¥3.80The company is down 13% from its price of CN¥4.36 on 31 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.Is New 90 Day High Low • Sep 28New 90-day low: CN¥3.94The company is down 8.0% from its price of CN¥4.28 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.収支内訳Dawei Technology (Guangdong) Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史XSSC:600589 収益、費用、利益 ( )CNY Millions日付収益収益G+A経費研究開発費31 Mar 26458-1021141431 Dec 25436-191061530 Sep 25412441071530 Jun 2540683861531 Mar 2541025931631 Dec 24405-22901730 Sep 243951761001630 Jun 24387124981631 Mar 24375128931631 Dec 2336783941630 Sep 23395-7203771730 Jun 23288-7793601431 Mar 23313-7733751431 Dec 22421-7453771530 Sep 22285-8342411530 Jun 22536-7682052131 Mar 22702-7201983631 Dec 21780-7192023730 Sep 211,139-1,2795886330 Jun 211,165-1,2406396031 Mar 211,126-1,2386184931 Dec 201,069-1,2266255030 Sep 201,119-9182364030 Jun 201,175-9132544731 Mar 201,306-6442555331 Dec 191,428-6242575830 Sep 191,5613431535330 Jun 191,6213751475131 Mar 191,6811511565531 Dec 181,7001541505230 Sep 181,7801611164530 Jun 181,754155866431 Mar 181,688138874631 Dec 171,643134943930 Sep 171,532119912830 Jun 171,520116120031 Mar 171,472104125031 Dec 161,437101119030 Sep 161,1877470030 Jun 161,0855079031 Mar 161,0003660031 Dec 159942162030 Sep 151,0071212030 Jun 151,07716100質の高い収益: 600589は現在利益が出ていません。利益率の向上: 600589は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 600589は利益を出していないが、過去 5 年間で年間57.6%の割合で損失を削減してきた。成長の加速: 600589の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 600589は利益が出ていないため、過去 1 年間の収益成長をIT業界 ( -5.2% ) と比較することは困難です。株主資本利益率高いROE: 600589は現在利益が出ていないため、自己資本利益率 ( -16.28% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 20:35終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dawei Technology (Guangdong) Group Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Zhi Yi KangHuatai Research
お知らせ • Mar 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Dec 26Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026
お知らせ • Sep 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • Jun 30Dawei Technology (Guangdong) Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
お知らせ • Mar 28Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Dec 27Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 19, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 19, 2025
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lijun Deng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 22+ 1 more updateDawei Technology (Guangdong) Group Co., Ltd. announced that it expects to receive CNY 300 million in fundingDawei Technology (Guangdong) Group Co., Ltd announced a private placement to issue A shares at an issue price of not less than 80% of the average price in the 20 trading days before the pricing reference date for gross proceeds of not more than CNY 300,000,000 on April 20, 2026. The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved in the 7th Meeting of the 10th Directorate and is subject to Company’s Annual Shareholders Meeting of 2025 for approval. The transaction will include participation from not more than 35 investors.
お知らせ • Mar 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Dec 26Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026
お知らせ • Sep 30Dawei Technology (Guangdong) Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • Jun 30Dawei Technology (Guangdong) Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
お知らせ • Mar 28Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Mar 19Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025, at 15:00 China Standard Time. Location: 13F, Tower B, 33 Building, Xiaoyun Road, Maizidian Subdistrict, Chaoyang District, Beijing China
お知らせ • Dec 27Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 19, 2025Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 19, 2025
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.005 (vs CN¥0.061 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.005 (up from CN¥0.061 loss in 3Q 2023). Revenue: CN¥101.2m (up 8.1% from 3Q 2023). Net income: CN¥9.55m (up CN¥52.5m from 3Q 2023). Profit margin: 9.4% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥3.70, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
お知らせ • Sep 30Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 21Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥2.55, the stock trades at a trailing P/E ratio of 30.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.
New Risk • Sep 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Aug 23Second quarter 2024 earnings released: CN¥0.039 loss per share (vs CN¥0.053 loss in 2Q 2023)Second quarter 2024 results: CN¥0.039 loss per share. Revenue: CN¥106.6m (up 13% from 2Q 2023). Net loss: CN¥41.6m (loss widened 12% from 2Q 2023).
New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
お知らせ • Jun 28Guangdong Rongtai Industry Co.,Ltd to Report First Half, 2024 Results on Aug 23, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report first half, 2024 results on Aug 23, 2024
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥3.14, the stock trades at a trailing P/E ratio of 36.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥3.99, the stock trades at a trailing P/E ratio of 46x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 107% over the past three years.
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Supervisor Weibin Xu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥4.00, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years.
お知らせ • Mar 29Guangdong Rongtai Industry Co.,Ltd to Report Q1, 2024 Results on Apr 26, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Mar 19Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024, at 15:00 China Standard Time. Location: 13F, Tower B, No. 33, Xiaoyun Road, Chaoyang District, Beijing China
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥1.06 loss in FY 2022)Full year 2023 results: EPS: CN¥0.06 (up from CN¥1.06 loss in FY 2022). Revenue: CN¥366.8m (down 13% from FY 2022). Net income: CN¥82.6m (up CN¥828.0m from FY 2022). Profit margin: 23% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
New Risk • Jan 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥200m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-CN¥791m). Earnings have declined by 29% per year over the past 5 years. Shareholders have been substantially diluted in the past year (110% increase in shares outstanding).
お知らせ • Dec 30Guangdong Rongtai Industry Co.,Ltd to Report Fiscal Year 2023 Results on Mar 22, 2024Guangdong Rongtai Industry Co.,Ltd announced that they will report fiscal year 2023 results on Mar 22, 2024
お知らせ • Sep 30Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2023 Results on Oct 28, 2023Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023
Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Xiaoxuan Liu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
New Risk • Aug 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥279m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥279m free cash flow). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Negative equity (-CN¥748m). Earnings have declined by 35% per year over the past 5 years.
New Risk • Aug 10New major risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CN¥711m). Earnings have declined by 40% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
Reported Earnings • Apr 26Full year 2022 earnings released: CN¥1.06 loss per share (vs CN¥1.01 loss in FY 2021)Full year 2022 results: CN¥1.06 loss per share (further deteriorated from CN¥1.01 loss in FY 2021). Revenue: CN¥421.1m (down 46% from FY 2021). Net loss: CN¥745.4m (loss widened 5.1% from FY 2021). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 27Third quarter 2022 earnings released: CN¥0.003 loss per share (vs CN¥0.053 loss in 3Q 2021)Third quarter 2022 results: CN¥0.003 loss per share (improved from CN¥0.053 loss in 3Q 2021). Net loss: CN¥2.05m (loss narrowed 95% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Aug 27Second quarter 2022 earnings released: CN¥0.046 loss per share (vs CN¥0.025 profit in 2Q 2021)Second quarter 2022 results: CN¥0.046 loss per share (down from CN¥0.025 profit in 2Q 2021). Revenue: CN¥119.3m (down 58% from 2Q 2021). Net loss: CN¥31.2m (down 278% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.019 loss per share (vs CN¥0.018 loss in 1Q 2021)First quarter 2022 results: CN¥0.019 loss per share (down from CN¥0.018 loss in 1Q 2021). Revenue: CN¥198.6m (down 28% from 1Q 2021). Net loss: CN¥13.6m (loss widened 8.3% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.
Reported Earnings • Oct 31Third quarter 2021 earnings released: CN¥0.053 loss per share (vs CN¥0.002 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥236.7m (down 9.6% from 3Q 2020). Net loss: CN¥37.3m (down CN¥38.6m from profit in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 28Second quarter 2021 earnings released: EPS CN¥0.025 (vs CN¥0.012 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥284.9m (up 14% from 2Q 2020). Net income: CN¥17.5m (up 106% from 2Q 2020). Profit margin: 6.1% (up from 3.4% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 03Full year 2020 earnings released: CN¥1.73 loss per share (vs CN¥0.76 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CN¥1.07b (down 27% from FY 2019). Net loss: CN¥1.22b (loss widened 126% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Jan 25New 90-day low: CN¥2.82The company is down 27% from its price of CN¥3.84 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period.
Is New 90 Day High Low • Jan 06New 90-day low: CN¥3.18The company is down 22% from its price of CN¥4.08 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
Is New 90 Day High Low • Dec 14New 90-day low: CN¥3.49The company is down 19% from its price of CN¥4.31 on 16 September 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.
Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥831.7m, with earnings decreasing by CN¥1.17b from the prior year. Total revenue was CN¥1.14b over the last 12 months, down 27% from the prior year.
Is New 90 Day High Low • Oct 29New 90-day low: CN¥3.80The company is down 13% from its price of CN¥4.36 on 31 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Sep 28New 90-day low: CN¥3.94The company is down 8.0% from its price of CN¥4.28 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.